.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Accenture
Farmers Insurance
Chinese Patent Office
Citi
Boehringer Ingelheim
Johnson and Johnson
Healthtrust
Federal Trade Commission
Daiichi Sankyo

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for Patent: ➤ Sign Up

« Back to Dashboard

Details for Patent: ➤ Sign Up

Title: Insecticide and miticide compositions containing A83543 compounds
Abstract:Fermentation product A83543, comprising major components A83543A and A83543D and minor components A83543B, A83543C, A83543E, A83543F, A83543G, A83543H and A83543J, is produced by a newly described species, Saccharopolyspora spinosa. The A83543 components and their acid-addition salts (A83543 compounds) are useful as insecticides, particularly against Lepidoptera and Diptera species. Insecticidal, miticidal or ectoparasiticidal combinations, compositions and methods are provided.
Inventor(s): Boeck; LaVerne D. (Indianapolis, IN), Chio; Hang (Greenfield, IN), Eaton; Tom E. (Greenwood, IN), Godfrey, Jr.; Otis W. (Greenwood, IN), Michel; Karl H. (Indianapolis, IN), Nakatsukasa; Walter M. (Indianapolis, IN), Yao; Raymond C. (Carmel, IN)
Assignee: DowElanco (Indianapolis, IN)
Filing Date:Jun 07, 1995
Application Number:08/479,500
Claims:1. An ectoparasiticidal composition comprising a physiologically-acceptable inert carrier and a compound of the formula ##STR4## wherein R is H or a group selected from ##STR5## R.sup.2 is ##STR6## R.sup.1, R.sup.3, R.sup.5 and R.sup.6 are hydrogen or methyl; R.sup.4 is methyl or ethyl; and provided that R, R.sup.1, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 must be present in one of the following combinations:

or an acid addition salt of a compound wherein R is other than hydrogen.

2. An ectoparasiticidal composition of claim 1 in the form of a feed premix wherein the inert carrier is orally acceptable.

3. An ectoparasiticidal composition of claim 1 wherein the compound is selected from ##STR7## wherein R is H or a group selected from ##STR8## R.sup.2 is ##STR9## R.sup.1, R.sup.3, R.sup.5 and R.sup.6 are hydrogen or methyl; R.sup.4 is methyl or ethyl; and provided that R, R.sup.1, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 must be present in one of the following combinations:

or an acid addition salt of a compound wherein R is other than hydrogen

or a physiologically acceptable salt thereof.
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Moodys
Covington
Citi
Express Scripts
Baxter
Argus Health
Harvard Business School
QuintilesIMS
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot